Featured Research

from universities, journals, and other organizations

New data emerges on liver transplant survival rates

Date:
November 25, 2009
Source:
Wiley-Blackwell
Summary:
Researchers compared the outcomes of cirrhotic patients who underwent liver transplants for nonalcoholic steatohepatitis (NASH) versus alcoholic liver disease (ETOH) and found no statistically significant differences in post-transplant survival rates between the NASH and ETOH groups.

Researchers at the University of Miami School of Medicine compared the outcomes of cirrhotic patients who underwent liver transplants for nonalcoholic steatohepatitis (NASH) versus alcoholic liver disease (ETOH) and found no statistically significant differences in post-transplant survival rates between the NASH and ETOH groups.

Related Articles


Study findings are presented in the December issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, NASH affects 2%-5% of Americans and ranks as one of the major causes of cirrhosis in the U.S. behind hepatitis C and alcoholic liver disease. Incidences of both NASH and nonalcoholic fatty liver disease (NAFLD) are increasing, possibly because of the greater number of Americans with obesity. Obesity also contributes to diabetes and high blood cholesterol, which can further complicate the health of someone with NASH. Because it is often a "silent" liver disease, NASH can lead to cirrhosis and permanent damage. Once serious scarring or cirrhosis is present, few treatments can halt the progression. Liver transplantation remains the only treatment for advanced cirrhosis with liver failure and is increasingly performed in people with NASH.

Vishal Bhagat, M.D, and colleagues demonstrated that liver transplant is an appropriate treatment for NASH patients, with survival rates comparable to those for ETOH patients. The team performed a retrospective chart review on all patients who underwent liver transplant for cryptogenic cirrhosis with NASH phenotype and alcoholic cirrhosis at the University of Miami from January 1997 through January 2007.

Cryptogenic cirrhosis was defined by absence of significant alcohol use (>20 gm/day), negative tests for viral hepatitis, negative autoimmune markers such as anti-nuclear antibody and anti-mitochondrial antibody, and negative markers for hemochromatosis, Wilson disease and alpha-1 antitrypsin deficiency.

The alcoholic cirrhosis (ETOH) group included patients who had history of significant alcohol, had no biochemical, serological and histological evidence of other known causes of cirrhosis, and underwent liver transplant from January 1997 through January 2007. Patients with hepatocellular carcinoma (HCC) and alcoholic cirrhosis with NASH phenotype were excluded from the ETOH group.

Baseline data on alcohol use, BMI, blood pressure and fasting serum levels of glucose, total cholesterol and triglycerides was recorded for both groups prior to liver transplant and after 6 months post-liver transplant. Demographic information was also collected including: recipient age, recipient sex, recipient ethnicity, donor age, cold ischemia time, biopsy proven acute and/or chronic rejection, biopsy proven recurrence of moderate to severe steatohepatitis in the transplanted liver, causes of retransplantation, graft survival, causes of death and patient survival.

"Our study presents the largest patient population with the longest follow-up published so far on the survival of patients with NASH cirrhosis," said Dr. Bhagat. "We found that although there was a trend towards lower patient survival in the NASH group compared with the ETOH group, the difference was not statistically significant."

In both the NASH and ETOH groups, sepsis (with or without multisystem organ failure) was the most common cause of death post-liver transplant, which is consistent with previously published data, followed by cardiovascular causes in the NASH group and malignancies in the ETOH group. Although higher number of patients died from cardiovascular causes in the NASH group (26%) compared with the ETOH group (7%), the difference did not reach statistical significance. "Cardiovascular mortality among NASH patients was much higher than published autopsy results in liver transplant patients and stresses the importance of control of the metabolic syndrome post-transplant in NASH patients," added Dr. Bhagat.

In a related study also published in Liver Transplantation, researchers at the Cleveland Clinic lead by Arthur McCullough, M.D., found that the development of metabolic syndrome following liver transplantation is on the rise and is a significant contributor to cardiovascular complications and morbidity and mortality. "Cardiovascular mortality and higher infection rates among patients with post-transplant metabolic syndrome remains a concern," said Dr. McCullough. "There is clearly a need for prospective studies to help identify and validate risk factors for post-transplant metabolic syndrome and thereby develop interventional strategies."


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal References:

  1. Vishal Bhagat, Ayse L. Mindikoglu, Carmine G. Nudo, Eugene R. Schiff, Andreas Tzakis, Arie Regev. Outcomes of Liver Transplantation in Patients with Cirrhosis Due to Nonalcoholic Steatohepatitis Compared to Alcoholic Liver Disease. Liver Transplantation, Published Online: November 25, 2009 DOI: 10.1002/lt.21927
  2. Arthur J. McCullough, M Pagadala, S Dasarathy, B Eghtesad. Post-Transplant Metabolic Syndrome: An Epidemic Waiting to Happen. Liver Transplantation, Published Online: November 25, 2009 DOI: 10.1002/lt.21952

Cite This Page:

Wiley-Blackwell. "New data emerges on liver transplant survival rates." ScienceDaily. ScienceDaily, 25 November 2009. <www.sciencedaily.com/releases/2009/11/091125081620.htm>.
Wiley-Blackwell. (2009, November 25). New data emerges on liver transplant survival rates. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2009/11/091125081620.htm
Wiley-Blackwell. "New data emerges on liver transplant survival rates." ScienceDaily. www.sciencedaily.com/releases/2009/11/091125081620.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins